Loading
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Sept 2026 for Tenax Therapeutics, INC., €9,683.
Filing timeline
BuySaleChristopher Thomas Giordano
Insider track record
Disclosed buys
5
Disclosed sells
0
Signal history
Closed purchases
Market purchases
3
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +52.5%Entry US$8.15 · Close at T+90 US$12.43
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christopher Thomas Giordano: trading record in brief
Christopher Thomas Giordano appears in our data through filings on Tenax Therapeutics, Inc. shares, published by SEC (Form 4). In total, 7 filings cover trades dated from 18 November 2025 to 15 September 2026.
Every open-market trade on record is a purchase: 5 purchases worth €35k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 option exercises. In 2026 alone, the filings show 2 purchases and no sales.
In size, the median ticket on the buying side is €7,657. Of 5 purchases, 5 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
On 15 September 2026 came the latest disclosure, an open-market purchase for €9,683 in Tenax Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher Thomas Giordano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
6,000 shares@ US$1.8750.016% mcap13.2% of flowCommon StockSEC:0001871714-26-000002:0
Canonical exit: 10 Dec 2026 (T+90)
4,850 shares@ US$1.82210.012% mcap10.5% of flowCommon StockSEC:0001871714-26-000002:1
Canonical exit: 14 Dec 2026 (T+90)
219 shares@ US$3.5490.0011% mcap0.9% of flowCommon StockSEC:0001193125-26-303600:0
8,500 shares@ US$5.940.071% mcap60.6% of flowCommon StockSEC:0001193125-26-303600:1
1,612 shares@ US$7.754614.8% of flowCommon StockSEC:0001871714-25-000002:0
Canonical exit: 16 Feb 2026 (T+90)
5 of 5 declarations
